ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
6 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: Alex's Lemonade Stand Foundation Reach Awards
Alex's Lemonade Stand Foundation (ALSF) evolved from the front yard lemonade stand of cancer patient Alexandra “Alex” Scott (1996-2004) into a national fundraising movement to raise awareness and find cures for all childhood cancers.
Reach Awards are designed to move hypothesis-driven research toward the clinic. A successful application will identify an unmet clinical need relevant to the care of patients with pediatric cancer and describe how the work performed will allow for the translation of hypothesis-driven research to the clinic keeping broader clinical testing and implementation in view.
All Reach Award applications must be received by May 30, 2014 - 11:59 PM ET.
Maximum of $250,000 in total costs awarded over two years.
All applications must be submitted using ALSF’s online submission process.
The purpose of the Reach Award is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Award seeks to remove one of these barriers by providing support for important pre-clinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Thus, the goal of this award is to support selected “late translational” studies needed to ultimately initiate a clinical trial. Preference will be given to those research projects which, if funded, will result in the initiation of a clinical trial within two to three years.
Primary applicants may be Assistant, Associate or Professor level investigators who demonstrate a track record of discovery, investigation and external funding. Applicants may be M.D., D.O., Ph.D, or M.D./Ph.D. Applicants must have a demonstrated track record of pediatric cancer research with experience in translational research Multiple investigator applications that bring together pairs or teams of researchers with complementary expertise are encouraged. Phase I/II Trials are not eligible for funding by this grant mechanism.
Call for Applications: Alex's Lemonade Stand Foundation ‘A’ Awards
The ‘A’ Award is a three-year grant designed for the early career scientist who wants to establish their career in pediatric oncology research. The ideal applicant has an original project that is not currently being funded. Demonstration of outstanding mentorship and a future commitment to pediatric cancer investigation are critical components of a successful application. Institutional commitment to the career of the applicant is also expected.
All applications must be received by May 23, 2014 - 11:59 PM ET.
This award totals $450,000 over three years and is open to MD, MD/PhD and PhD candidates.
‘A’ Award Program Goals To encourage the best and brightest early career researchers to build lifelong careers and become leaders in the field of pediatric cancer research. To advance research that will lead to new treatments and cures impacting children with cancer.
Highlights NEW in 2014: ALSF increased the award to $450,000 over 3 years ($150,000 per year) Recipient will have the opportunity to speak at and attend Foundation events In addition to the grant funds, the "A‟ Award provides
-- reference books to enhance personal pediatric oncology library
-- equipment to enhance lab/project work up to $10,000
-- registration fees for one educational course or event
Eligibility Criteria (Updated for 2014!) Proposals must be aligned with ALSF's mission and "A‟ Award program goals. Applicants must have an M.D., Ph.D. or dual M.D., Ph.D. (D.O., MBBS or equivalent) and must not have achieved an appointment higher than assistant professor. In addition,
-- M.D. and M.D., Ph.D. Applicants
o M.D. or M.D., Ph.D. applicants must be no more than 6 years after finishing 3-year fellowship at the time the award would start (i.e. fellowship ended in 2008 or later) and be no more than 12 years since receiving the most recent professional degree (Ph.D, M.D., D.O., MBBS or equivalent) at the time the award would start. Preference will be given to applicants no more than 12 years since receiving the first professional degree.
o M.D. candidates who did not have a 3-year fellowship must have 3 years of research experience after M.D. was awarded and be no more than 12 years since receiving the M.D. at the time the award would start.
-- Ph.D. Applicants
o Ph.D. applicants must be no more than 6 years since being awarded Ph.D. (i.e., if Ph.D. is awarded in 2008 or later, applicant is eligible for 2014 "A‟ Award). A minimum of 75% of the applicant's time during "A‟ Award must be allocated as protected time for all research activities. Applicants holding K99/R00, R01 are not eligible.
Applicants MAY have research grants from other funding sources during the "A‟ Award period, but there must be clear documentation of mechanisms to avoid scientific and budgetary overlap. Current ALSF Grant Recipients
-- Applicants currently holding an ALSF 2012 Young Investigator Award, ending June 30, 2014, are eligible to apply.
-- Applicants currently holding an ALSF 2013 Young Investigator Award or are Center of Excellence Scholars are not eligible.
-- Applicants currently holding ALSF's Innovation, Reach, Phase I/II Infrastructure or Epidemiology grants are not eligible to apply for the 2014 "A‟ Award. Prior Young Investigator applicants: If you are submitting a Young Investigator application previously reviewed but not funded by ALSF for the "A‟ Award, you must complete the resubmission section: respond to critiques, describe changes and/or new data etc. A detailed mentoring plan for career development must be clearly articulated with appropriate letters of support. Institutional commitment to the applicant's career must be addressed. Funds must be granted to nonprofit institutions or organizations operating in the United States or Canada. Researchers need not be U.S. citizens.
Resubmissions: Only one resubmission of a previously reviewed "A‟ Award or Young Investigator proposal is permitted.
Call for Applications: Alex's Lemonade Stand Foundation Springboard Grants
Springboard Grants are in response to cut-backs in National Institutes of Health (NIH) funding of new R01 and P01 applications. The Springboard Grant is designed to jump-start new projects with high impact potential for childhood cancer research while other funding is sought.
All applications must be received by April 10, 2014 - 11:59 PM ET.
This is a one year award of $100,000 in total costs.
All applications must be submitted via ALSFgrants.org.
ALSF’s Springboard Grant is designed to support new National Institutes of Health (NIH)* R01 or P01 research projects which were scored less than or equal to the 20th percentile but were not funded. ALSF will support projects via this mechanism for a maximum of 12 months. If NIH funding is secured and begins before the end of this 12 month period, ALSF must be notified and will cease its financial support of the project. Projects funded via this mechanism that do not receive funding from the NIH within 12 months are not eligible to reapply for the ALSF Springboard Grant.
Eligibility: Researchers must have applied to the NIH for an R01 or P01 award and received notification dated within the last 6 months. (R01 Supplements are not eligible for Springboard Grants) Applications must have scored ≤25% but outside of the agency’s fundable range. If submitting a project from a NIH P01 application, the project must have scored at 3.0 or better in the initial review.
o If resubmitting the project to the NIH as a R01, only include the NIH project review.
o If resubmitting the project to the NIH in a P01, you must include the entire P01 review from the NIH. Applicants must be reapplying for an R01 or P01 award from the NIH within the next two NIH Grant cycles. The original NIH application must be aligned with ALSF’s mission, and thus must be directly relevant to pediatric cancer. Funds may be used for supplies, personnel, or PI’s salary and may not exceed $100,000. ALSF does not pay indirect costs.
Call for Applications: Alex's Lemonade Stand Foundation Bridge Grants
This is a one year award of $100,000 in total costs
ALSF’s Bridge Grant is designed to sustain research projects falling between the end of funding by the National Institutes of Health (NIH) R or P Award and the beginning of a competitively renewed NIH Award. ALSF will support projects via this mechanism for a maximum of 12 months. If NIH funding is secured and begins before the end of this 12 month period, ALSF must be notified and will cease its financial support of the project. Projects funded via this mechanism that do not receive funding from the NIH within 12 months are not eligible to reapply for the ALSF Bridge Grant.
Eligibility: Project must have been previously funded by NIH R01, R03, R21 or P01 Award. (R01 Supplements are not eligible for Bridge Grants) Researchers must have applied to the NIH for an R01 or P01 renewal for an ongoing project or to continue the project via new R01 or P01 and received notification dated within the last 6 months. The R01 application must have scored ≤35th percentile but outside of the agency’s fundable range. If submitting a project from a NIH P01 application, the project must have scored at 3.0 or better in the initial review.
o If resubmitting the project to the NIH as a R01, only include the NIH project review
o If resubmitting the project to the NIH in a P01, you must include the entire P01 review from the NIH Applicants must be reapplying for an R01 or P01 Award from the NIH within the next two NIH Grant cycles. The original NIH project must be aligned with ALSF’s mission, and thus must be directly relevant to pediatric cancer. Funds may be used for supplies, personnel, and PI’s salary and may not exceed $100,000. ALSF does not pay indirect costs.
Children’s Leukemia Research Association Research Grant Program
Each year, CLRA's Medical Advisory Committee, consisting of prominent internationally known and respected hematologists, reviews submitted research proposals from doctors nationwide.
Using your contributions, we fund research grants for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
The objectives of this committee are to direct the funds of the Association into the most promising projects, and where funding would not duplicate other funding sources.
With your help, we are getting closer every day! Because of the support of friends like you, the scientific community is making incredible strides in developing chemotherapy regimens that are extending the lives of leukemia patients. Not everyone under treatment goes into remission but our research grants are funding the examinations into why this is so, and how we can continue to combat leukemia.
How the CLRA Research Grant Program Works
Any doctor at the Ph.D. or MD level who is involved in research towards finding the causes and cure for leukemia may apply.
Simply access the form available on our Website and print, or call or write to us for one.
Please submit an original and three copies of your application prior to June 30 of each year. It is then reviewed by our Medical Advisory Committee. A decision is made by the following calendar year.
In order that we may fund as many projects as possible, grants are limited to a maximum of $30,000 each, subject to availability of funds.
Email Address: email@example.com
585 Stewart Avenue
Garden City, NY 11530
Damon Runyon-Sohn Pediatric Cancer Fellowship Award
Application due on or before: March 17, 2014
The Damon Runyon Cancer Research Foundation has joined together with the Sohn Conference Foundation, dedicated to curing pediatric cancers, to establish the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.
Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining his/her career goals.
Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible.
The primary criteria used to evaluate applicants are:
• potential impact of the research on pediatric cancer
• the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques and clarity of presentation)
• the qualifications, experience and productivity of both the candidate and the Sponsor
• the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate’s ability to conduct innovative and substantive research.
The proposed research and training environment should represent a new opportunity for the candidate to expand his/her scientific skill set. Direct extensions of the candidate’s graduate work (in approach, technique or exact area of study) will not be funded.
Damon Runyon-Sohn Pediatric Cancer Fellowships are granted for a three-year term with second- and third-year funding contingent upon satisfactory progress reports. Fellows in their first- and third-years of funding will attend Damon Runyon Fellows’ Retreats designed to foster collaboration and interaction between scientists working in different fields relevant to cancer. All fellowship awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Damon Runyon-Sohn Pediatric Cancer Fellowship Award Committee.